[
    [
        {
            "time": "",
            "original_text": "高瓴资本大幅减持 凯莱英市值跌落千亿 减持股份",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "减持",
                    "凯莱英",
                    "市值跌落"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本大幅减持 凯莱英市值跌落千亿 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "药明康德：业绩增长难挽股东去意 一股东因违规减持遭立案调查 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "业绩增长",
                    "股东去意",
                    "违规减持",
                    "立案调查"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：业绩增长难挽股东去意 一股东因违规减持遭立案调查 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "业绩低于预期+高瓴资本减持 凯莱英市值跌落千亿 减持股份",
            "features": {
                "keywords": [
                    "业绩低于预期",
                    "高瓴资本",
                    "减持",
                    "凯莱英",
                    "市值跌落"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "业绩低于预期+高瓴资本减持 凯莱英市值跌落千亿 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]